Similar articles for PMID: 30404036

Year	Number of Results
1994	1
1997	1
2000	1
2001	3
2003	5
2004	3
2005	2
2006	1
2007	1
2008	1
2010	1
2011	3
2012	2
2013	2
2014	6
2015	12
2016	14
2017	16
2018	13
2019	23
2020	7
2021	6
2022	2
2023	1
2024	0

1

Tofacitinib for the Treatment of Pyoderma Gangrenosum.

Kochar B, Herfarth N, Mamie C, Navarini AA, Scharl M, Herfarth HH. Kochar B, et al. Clin Gastroenterol Hepatol. 2019 Apr;17(5):991-993. doi: 10.1016/j.cgh.2018.10.047. Epub 2018 Nov 4. Clin Gastroenterol Hepatol. 2019. PMID: 30404036 Free article.

2

Tofacitinib for the treatment of refractory pyoderma gangrenosum.

Orfaly VE, Kovalenko I, Tolkachjov SN, Ortega-Loayza AG, Nunley JR. Orfaly VE, et al. Clin Exp Dermatol. 2021 Aug;46(6):1082-1085. doi: 10.1111/ced.14683. Epub 2021 May 29. Clin Exp Dermatol. 2021. PMID: 33864685

3

Successful Treatment of Pyoderma Gangrenosum with Concomitant Tofacitinib and Infliximab.

Gregory MH, Ciorba MA, Deepak P, Christophi GP. Gregory MH, et al. Inflamm Bowel Dis. 2019 Jun 18;25(7):e87-e88. doi: 10.1093/ibd/izz015. Inflamm Bowel Dis. 2019. PMID: 30753456 No abstract available.

4

Tofacitinib, a useful option for the treatment of pyoderma gangrenosum in an ulcerative colitis patient.

Salmón Olavarría P, Rubio Iturria S, Nantes Castillejo Ó. Salmón Olavarría P, et al. Rev Esp Enferm Dig. 2021 Oct;113(10):733-734. doi: 10.17235/reed.2021.7977/2021. Rev Esp Enferm Dig. 2021. PMID: 33845581 Free article.

5

Recovery of nail dystrophy potential new therapeutic indication of tofacitinib.

Jaller JA, Jaller JJ, Jaller AM, Jaller-Char JJ, Ferreira SB, Ferreira R, Scheinberg M. Jaller JA, et al. Clin Rheumatol. 2017 Apr;36(4):971-973. doi: 10.1007/s10067-017-3574-0. Epub 2017 Feb 16. Clin Rheumatol. 2017. PMID: 28210825

6

Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.

Chatzinasiou F, Polymeros D, Panagiotou M, Theodoropoulos K, Rigopoulos D. Chatzinasiou F, et al. Acta Dermatovenerol Croat. 2016 Apr;24(1):83-5. Acta Dermatovenerol Croat. 2016. PMID: 27149138

7

[The role of biologic therapy in the treatment of extraintestinal manifestations and complications of inflammatory bowel disease].

Kujundzić M. Kujundzić M. Acta Med Croatica. 2013 Apr;67(2):195-201. Acta Med Croatica. 2013. PMID: 24471303 Review. Croatian.

8

Clinical experiences on alopecia areata treatment with tofacitinib: A study of 63 patients.

Serdaroğlu S, Engin B, Çelik U, Erkan E, Aşkın Ö, Oba Ç, Kutlubay Z. Serdaroğlu S, et al. Dermatol Ther. 2019 May;32(3):e12844. doi: 10.1111/dth.12844. Epub 2019 Feb 7. Dermatol Ther. 2019. PMID: 30693634 No abstract available.

9

Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials.

Panés J, Sandborn WJ, Schreiber S, Sands BE, Vermeire S, D'Haens G, Panaccione R, Higgins PDR, Colombel JF, Feagan BG, Chan G, Moscariello M, Wang W, Niezychowski W, Marren A, Healey P, Maller E. Panés J, et al. Gut. 2017 Jun;66(6):1049-1059. doi: 10.1136/gutjnl-2016-312735. Epub 2017 Feb 16. Gut. 2017. PMID: 28209624 Free PMC article. Clinical Trial.

10

Oral tofacitinib monotherapy in Korean patients with refractory moderate-to-severe alopecia areata: A case series.

Park HS, Kim MW, Lee JS, Yoon HS, Huh CH, Kwon O, Cho S. Park HS, et al. J Am Acad Dermatol. 2017 Nov;77(5):978-980. doi: 10.1016/j.jaad.2017.06.027. J Am Acad Dermatol. 2017. PMID: 29029911 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

114 results

Results by year